KC Pharma   Report issue

For profit Phase 2
Founded: Pomona CA United States (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2016
NCT02679144
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

KC Pharma | KidsCure Pharmaceuticals

Active Ingredients

Drugs in Phase 2 Trials (1)

eflornithine (ornidyl) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuroblastoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1